Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease.

Mascia K, Borish L, Patrie J, Hunt J, Phillips CD, Steinke JW.

Ann Allergy Asthma Immunol. 2005 Jun;94(6):652-7.

PMID:
15984597
2.

Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma.

Mascia K, Haselkorn T, Deniz YM, Miller DP, Bleecker ER, Borish L; TENOR Study Group.

J Allergy Clin Immunol. 2005 Nov;116(5):970-5. Epub 2005 Oct 3.

PMID:
16275362
3.
4.

Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity.

Celik GE, Erkekol FO, Misirligil Z, Melli M.

Clin Exp Allergy. 2007 Oct;37(10):1494-501.

PMID:
17883729
5.

The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.

Berges-Gimeno MP, Simon RA, Stevenson DD.

Ann Allergy Asthma Immunol. 2002 Nov;89(5):474-8.

PMID:
12452205
6.
7.

Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis.

Dursun AB, Woessner KA, Simon RA, Karasoy D, Stevenson DD.

Ann Allergy Asthma Immunol. 2008 May;100(5):420-5. doi: 10.1016/S1081-1206(10)60465-6.

PMID:
18517072
8.

Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.

Bochenek G, Kuschill-Dziurda J, Szafraniec K, Plutecka H, Szczeklik A, Nizankowska-Mogilnicka E.

J Allergy Clin Immunol. 2014 Jan;133(1):98-103.e1-6. doi: 10.1016/j.jaci.2013.07.004. Epub 2013 Aug 27.

PMID:
23993879
9.

Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma?

Awad OG, Lee JH, Fasano MB, Graham SM.

Laryngoscope. 2008 Jul;118(7):1282-6. doi: 10.1097/MLG.0b013e318170af1e.

PMID:
18475212
10.

Chronic sinusitis in severe asthma is related to sputum eosinophilia.

ten Brinke A, Grootendorst DC, Schmidt JT, De Bruïne FT, van Buchem MA, Sterk PJ, Rabe KF, Bel EH.

J Allergy Clin Immunol. 2002 Apr;109(4):621-6.

PMID:
11941310
11.

Asthma outcomes after endoscopic sinus surgery in aspirin-tolerant versus aspirin-induced asthmatic patients.

Awad OG, Fasano MB, Lee JH, Graham SM.

Am J Rhinol. 2008 Mar-Apr;22(2):197-203. doi: 10.2500/ajr.2008.22.3148.

PMID:
18416980
12.

Natural history and clinical features of aspirin-exacerbated respiratory disease.

Fahrenholz JM.

Clin Rev Allergy Immunol. 2003 Apr;24(2):113-24. Review.

PMID:
12668892
13.

Molecular and cellular staging for the severity of chronic rhinosinusitis.

Kountakis SE, Arango P, Bradley D, Wade ZK, Borish L.

Laryngoscope. 2004 Nov;114(11):1895-905.

PMID:
15510011
14.

The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions.

Berges-Gimeno MP, Simon RA, Stevenson DD.

Clin Exp Allergy. 2002 Oct;32(10):1491-6.

PMID:
12372130
15.

Diagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease in asthma.

Chang HS, Park JS, Jang AS, Park SW, Uh ST, Kim YH, Park CS.

Allergy Asthma Immunol Res. 2011 Oct;3(4):256-64. doi: 10.4168/aair.2011.3.4.256. Epub 2011 Jul 1.

16.

Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.

Simon RA.

Curr Allergy Asthma Rep. 2004 Jan;4(1):17-24. Review.

PMID:
14680616
17.

Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.

Mullol J, Picado C.

Immunol Allergy Clin North Am. 2013 May;33(2):163-76. doi: 10.1016/j.iac.2012.11.002. Epub 2012 Dec 23. Review. Erratum in: Immunol Allergy Clin North Am. 2013 Aug;33(3):xi.

PMID:
23639706
18.

Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.

Steinke JW, Liu L, Huyett P, Negri J, Payne SC, Borish L.

J Allergy Clin Immunol. 2013 Oct;132(4):856-65.e1-3. doi: 10.1016/j.jaci.2013.05.008. Epub 2013 Jun 24.

19.

Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.

Stevenson DD, Mehra PK, White AA, Gupta S, Woessner KM, Simon RA.

J Allergy Clin Immunol. 2005 Oct;116(4):755-60. Epub 2005 Jul 21.

PMID:
16210047
20.

Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.

El Miedany Y, Youssef S, Ahmed I, El Gaafary M.

Ann Allergy Asthma Immunol. 2006 Jul;97(1):105-9.

PMID:
16892790
Items per page

Supplemental Content

Write to the Help Desk